Cita APA

Otoya, I., Valdiviezo, N., Morante, Z., Calle, C., Ferreyra, Y., Huarcaya-Chombo, N., . . . Gomez, H. (2024). Subcutaneous Trastuzumab: An Observational Study of Safety and Tolerability in Patients with Early HER2-Positive Breast Cancer.

Citación estilo Chicago

Otoya, I., et al. Subcutaneous Trastuzumab: An Observational Study of Safety and Tolerability in Patients With Early HER2-Positive Breast Cancer. 2024.

Cita MLA

Otoya, I., et al. Subcutaneous Trastuzumab: An Observational Study of Safety and Tolerability in Patients With Early HER2-Positive Breast Cancer. 2024.